Candesartan reduces oxidative stress and inflammation in patients with essential hypertension

被引:86
作者
Dohi, Y [1 ]
Ohashi, M
Sugiyama, M
Takase, H
Sato, K
Ueda, R
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Div Hypertens & Vasc Res Internal Med & Mol Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Enshu Gen Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan
[3] Johoku Hosp, Dept Internal Med, Nagoya, Aichi, Japan
关键词
angiotensin II type-1 receptor; C-reactive protein; hypertension; inflammation; oxidative stress;
D O I
10.1291/hypres.26.691
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The present study was designed to test the hypothesis that blockade of angiotensin 11 type-1 receptors reduces oxidative stress and inflammation in patients with essential hypertension. The study population comprised 132 hypertensive patients, some receiving and others not receiving medical treatment. At enrollment their systolic and/or diastolic blood pressures were greater than or equal to140 and/or greater than or equal to90 mmHg, respectively. The serum concentration of C-reactive protein, and the urine concentrations of 8-epi-prostagiandin F-2alpha and 8-hydroxydeoxyguanosine were measured at baseline and after 12 weeks of treatment either with an angiotensin 11 type-1 receptor blocker, candesartan (8 mg daily) (age 64 +/- 12 years; male/female 28/39; n=67), or other antihypertensive agents that do not block the renin-angiotensin system (age 65 +/- 10 years, male/female 25/40, n=65). Candesartan reduced the levels of C-reactive protein (from 0.07 +/- 0.04 [median value median absolute deviation] to 0.06 +/- 0.03 mg/dl, p<0.0001), 8-epi-prostagiandin F-2alpha (from 210 +/- 92 to 148 +/- 59 pg/mg creatinine, p<0.0001), and 8-hydroxydeoxyguanosine (from 5.7 +/- 1.9 to 4.0 +/- 1.3 ng/mg creatinine, p<0.0001), while the levels of these markers were not altered after the treatment with other anti hypertensive agents. Blood pressure decreased by a similar amount in both groups, and the reductions in the levels of the markers did not correlate with that of blood pressure. These results suggest that candesartan reduces oxidative stress and inflammation in hypertensive patients independently of its effects on blood pressure. This may provide useful information for determining therapeutic strategies to minimize tissue injury by inflammation and oxidative stress in hypertensive patients.
引用
收藏
页码:691 / 697
页数:7
相关论文
共 41 条
[1]   Angiotensin II and catecholamines increase plasma levels of 8-epi-prostaglandin F2α with different pressor dependencies in rats [J].
Aizawa, T ;
Ishizaka, N ;
Usui, S ;
Ohashi, N ;
Ohno, M ;
Nagai, R .
HYPERTENSION, 2002, 39 (01) :149-154
[3]   Is C-reactive protein an independent risk factor for essential hypertension? [J].
Bautista, LE ;
López-Jaramillo, P ;
Vera, LM ;
Casas, JP ;
Otero, AP ;
Guaracao, AI .
JOURNAL OF HYPERTENSION, 2001, 19 (05) :857-861
[4]   Vascular inflammation and the renin-angiotensin system [J].
Brasier, AR ;
Recinos, A ;
Eledrisi, MS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1257-1266
[5]   8-Epi PGF(2 alpha): Specific analysis of an isoeicosanoid as an index of oxidant stress in vivo [J].
Delanty, N ;
Reilly, M ;
Pratico, D ;
Fitzgerald, DJ ;
Lawson, JA ;
FitzGerald, GA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (01) :15-19
[6]  
FUKAI T, 1997, CIRC RES, V80, P45
[7]   ANGIOTENSIN-II STIMULATES NADH AND NADPH OXIDASE ACTIVITY IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
GRIENDLING, KK ;
MINIERI, CA ;
OLLERENSHAW, JD ;
ALEXANDER, RW .
CIRCULATION RESEARCH, 1994, 74 (06) :1141-1148
[8]   NAD(P)H oxidase - Role in cardiovascular biology and disease [J].
Griendling, KK ;
Sorescu, D ;
Ushio-Fukai, M .
CIRCULATION RESEARCH, 2000, 86 (05) :494-501
[9]   Acute production of vascular superoxide by angiotensin II but not by catecholamines [J].
Kawazoe, T ;
Kosaka, H ;
Yoneyama, H ;
Hata, Y .
JOURNAL OF HYPERTENSION, 2000, 18 (02) :179-185
[10]  
Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963